David Montez

2014

In 2014, David Montez earned a total compensation of $668.7K as Former Controller and Chief Accounting Officer at PDL BioPharma, a 222% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$299,933
Salary$249,600
Stock Awards$91,140
Other$28,000
Total$668,673

Montez received $299.9K in non-equity incentive plan, accounting for 45% of the total pay in 2014.

Montez also received $249.6K in salary, $91.1K in stock awards and $28K in other compensation.

Rankings

In 2014, David Montez's compensation ranked 9,244th out of 13,032 executives tracked by ExecPay. In other words, Montez earned more than 29.1% of executives.

ClassificationRankingPercentile
All
9,244
out of 13,032
29th
Division
Manufacturing
3,473
out of 4,965
30th
Major group
Chemicals And Allied Products
1,174
out of 1,690
31st
Industry group
Drugs
932
out of 1,369
32nd
Industry
Biological Products, Except Diagnostic Substances
172
out of 241
29th
Source: SEC filing on April 20, 2016.

Montez's colleagues

We found four more compensation records of executives who worked with David Montez at PDL BioPharma in 2014.

2014

John McLaughlin

PDL BioPharma

Chief Executive Officer

2014

Christopher Stone

PDL BioPharma

General Counsel

2014

Peter Garcia

PDL BioPharma

Chief Financial Officer

2014

Danny Hart

PDL BioPharma

Vice President, Business Development

You may also like